Browsing BEAR Day 2020 by Subject "School of Medicine"
Now showing items 1-11 of 11
-
Activation of Lanthionine Synthetase C-like 2 Protein (LANCL2) Attenuates Spinal Neuroinflammation and Neuropathic Pain in RatsThe LANCL2 protein represents a novel target for the alleviation of neuropathic pain through administration of its natural ligand abscisic acid.
-
Calcitriol and Its Eeffects on Staphylococcal Enterotoxin B (SEB)-Induced Inflammation in Mice Spleen CellsThe active form of vitamin D, Calcitriol, upregulates different anti-inflammatory pathway. In this study we investigated effect of Calcitriol on Staphylococcal enterotoxin B (SEB)-induced inflammation in spleen cells.
-
Efficacy of C-Fos Inhibition In Patch Compartment Upon Habitual Methamphetamine AdministrationThe study evaluates whether deactivating C-Fos neuronal expression in patch compartment decreases habit formation in methamphetamine administration
-
GLP-1 Receptor Agonists Improve Cerebrovascular Integrity and Vascular Cognitive Impairment and Dementia via Recovery of Brain Pericytes Functions in Diabetic MiceDiabetic animals treated with GLP-1R agonists demonstrate an improvement in memory and learning through recovery of brain pericyte activity.
-
Linkages of the Epstein-Barr Virus in Developing NationsThis project aims to examine and analyze the effects of Epstein-Barr Virus in developing nations.
-
Methamphetamine Induced Immune DysregulationIn this study we aim to analyze how methamphetamine modulates Th1-Th2-Treg-Th17-Th22-Th9 (ThX) pathways in CTX-TNA2 astrocyte cell line.
-
Proximal Tubular Hypertrophy Enhances Basolateral Uptake of MercuryAnimals were used to test the effects of mercury in control and hypertrophied kidneys
-
Reduction of Angiotensin II Induced Hypertension and Cardiac Fibrosis with GLP-1 Receptor Agonist and DPP-4 Inhibitor via Decreasing NADPH Oxidase ExpressionThis study entails focus on Ang II infused cardiac fibrosis, NADPH oxidases role in the inflammation pathway, and possible treatment options in GLP-1 agonists and DPP-4 inhibitors
-
Role of Sumoylation in the EBV Life-CycleWe examined the effects of a novel, SAE small molecule inhibitor, ML-792, on protein sumoylation in multiple B cell lines infected with EBV.
-
Targeting Chronic Myelogenous Leukemia with Imatinib and Glycyrrhizic Acid Combination TherapyExamining the efficacy of an imatinib and glycyrrhizic acid combination treatment on chronic myelogenous leukemia cell lines. As well as examining the mechanism of action of glycyrrhizic acid.
-
Understanding the Nature of Glycyrrhizic Acid in Breast Cancer TreatmentModulation of HA metabolisms, both production and cleavage, by BC provides for a protective environment preventing the cells from therapy induced cell death or apoptosis. We suggest that inhibition of HA degradation by HYAL may be key in limiting the migration and progression of breast cancer.
